BridgeMD
Compares treatment options for Benign Prostatic Hyperplasia
Official title Artery Embolization vs Operation of Benign Prostate Hyperplasia
ClinicalTrials.gov ID: NCT04084938
What this study is testing
- What it's testing
- Aim of the study is to compare prostate artery embolization (PAE) to the established surgical treatment for patient acceptance, morbidity, complications, and the functional outcomes. To compare length of stay, hospital costs and time for recovery.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults, men only
You may be able to join if
- LUTS from Benign Prostate Hyperplasia (BPH) with moderate and severe IPSS score (IPSS \> 8) and QoL = or \>3
- and refractory to medical treatment for at least 6 months or the patient is unwilling to accept medical treatment
- or BPH using permanent or intermittent catheterization
- Prostate volume \> 50 ml
- Signed informed consent
You likely can't join if
- Urological disorders: evidence of clinically significant prostate cancer [as defined by START criteria] on prostate biopsy (27,28), prostatitis...
- Renal insufficiency defined as Glomerular Filtration Rate \< 30 ml/min/1,73m2
- Known severe reactions to iodine-based contrast or gadolinium-based contrast
- Previous prostate operation
- CT examination reveals no access to the prostate arteries.
The study team makes the final eligibility decision.
Where it's taking place
- Oslo, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oslo, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.